United States · FDA National Drug Code directory
Cetirizine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 37835-611_36d0b7f3-2156-873a-e063-6294a90ac015
- Product NDC
- 37835-611
- Form
- TABLET
- Composition / generic term
- Cetirizine hydrochloride
- Labeler
- Bi-Mar
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250501
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET in 1 BOTTLE (37835-611-14) · 37835-611-14
- 35 TABLET in 1 BOTTLE (37835-611-35) · 37835-611-35
- 90 TABLET in 1 BOTTLE (37835-611-90) · 37835-611-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →